Ariana Adjani
Co-Founder
Fine Treatment
John Lee Allen
Managing Partner
RYSE Asset Management
Renee Aguiar-Lucander
CEO
Calliditas Therapeutics
Khatereh Ahmadi
Head of Search and Evaluation Europe and Middle East BD&L Team
MSD
Mehdi Ainouche
Principal
Jeito
Michael Altorfer
Chief Executive Officer
Swiss Biotech Association
Madeleine Armstrong
News Editor
Evaluate
David Atkins
Chief Executive Officer
Congenica
Assaf Barnea
CEO
Sanara Ventures
Simon Basham
Head of Cyber & TMT Broking UK
WTW
Mats Berggren
Head of Digital Growth Opportunities and Innovation
Merck
Xavier Bertrand
VP & GM EMEA Healthcare Services and Alliances
Boston Scientific
Maina Bhaman
Partner
Sofinnova Partners
Robin Bhattacherjee
CEO
Actimed Therapeutics
Martin-Immanuel Bittner
CEO
Arctoris
Bernd Boidol
CEO
Proxygen
Georg Bortlein
CEO
Highlife Medical
Jasper Bos
General Partner, Forbion
CEO, Forbion European Acquisition
Peter Bowness
Director, International Regulatory Affairs, MCRA
Former Senior Regulator, BSI
Viola Bronsema
CEO and Secretary General
BIO Deutschland
Seamus Browne
Head of Industry Partnerships
Royal College of Surgeons in Ireland
Roel Bulthuis
Managing Director
INKEF Capital
Drew Burdon
Partner
EQT Life Sciences
Elizabeth Cairns
Medtech Reporter
Vantage
Jose Calle Gordo
Managing Partner
Valiance
Brittanie Campbell
Account Executive
Greenlight Guru
Matt Cardinal
VP Strategy & Program Leadership
Halloran
Björn Carlsson
Principal Consultant & Advisory Board Member
NDA Group
Steve Carney
Editor
Drug Discovery Today
John Cassidy
Investment Director Life Sciences & HealthTech
Softbank Vision Fund
Richard Cassidy
SVP Rx+ Business Accelerator
Astellas Pharma
Chris Chamberlain
Executive Director Experimental Medicine
AstraZeneca
Alexander Chekan
Chief of Staff
Palta
Djork-Arne Clevert
Director Machine Learning
Bayer
Megan Coder
Vice President of Global Policy
Digital Therapeutics Alliance
Jean-Philippe Combal
CEO
Vivet Therapeutics
Yuehua Cong
BD Executive Director
Simcere Pharmaceutical Group
Juliette Cook
Vice President Quality and Regulatory Affairs
Implantica Management AG
Jette Cowan
Head Of Commercial – Pharmaceuticals
RSSL
Sarah Cowlishaw
Partner
Covington & Burling
Ian Coyne
Executive Director Global Information & Intelligence
Coulter Partners
David Crome
Managing Director Compliance UK
ProPharma Group
Ian Crosbie
CEO
Sequana Medical NV
Maria Dahl
Chief Operating Officer and Head, Europe
Innovent Biologics
Victoria Darbyshire
Equity Analyst
J.P. Morgan
Nach Dave
Vice President Development Strategy
Premier Research
Mark Davies
SVP of Informatics and Data
BenevolentAI
Mark Davies
Chief Medical Officer EMEA
IBM Watson Health
John Dawson
Director
Oxford Biomedica
Lucas de Breed
Founder
August
SPEAKER NAME
Job, Designation
- BIOTECH AND MONEY
Ros Deegan
CEO
OMass Therapeutics
Graham Defries
Partner
Goodwin
Christian Dillon
CSO
Phoremost
Guy Dingley
Partner
Covington & Burling
Mark Dorff
Partner
Brown Rudnick
Angela Drew
Director Regulatory Strategy
Premier Consulting
Jonathan Edgeworth
Consultant Microbiologist and Infectious Disease Clinician
Guys and St Thomas NHS Foundation Trust
Abie Ekangaki
Vice President, Statistical Consulting
Premier Research
Annemijn Eschauzier
Mentor
former CMO Women's Health, GE
Peter Finnie
Partner
Potter Clarkson
Rachel Ford Hutman
Founder and CEO
Ford Hutman Media
Beth Fordham-Meier
VP, Business Development, BioConsulting
Lumanity
Jason Foster
CEO
Ori Biotech
Zina Fragkiadaki
Senior Reporter
HealthInvestor UK
Hayley French
Investor
Vesalius Biocapital Partners
Matt Fujisawa
Global Head of Corporate Development
KRY
Marta Gaia Zanchi
Founder and Managing Partner
Nina Capital
Robert Garber
Partner
7WireVentures
Neil Gomes
System SVP, Digital Human Experiences
Common Spirit Health
Lala Gregorek
Healthcare Analyst
Trinity Delta
Franc Gregori
Analyst
Trinity Delta
Gregoire Guillet
Chief Business & Value Officer – WeHealth Digital Medicine
Servier
Andrew Hack
Managing Director
Bain Capital Life Sciences
Sofia Håkansson Buch
VP Cell Therapy CMC
Novo Nordisk
Brian Hakim
Director Business Development
MedTecX
James Halstead
Partner
Covington & Burling
Alex Hamilton
Partner
Syncona
Giles Hamilton
CEO
ODx Innovations
Luke Hares
CTO
CMR Surgical
Deborah Harland
Partner
SR One
Mike Harris
CEO
Biocomposites
Steven Harris
Chairman
CS Pharmaceuticals
Andrew Harrow
Partner
Goodwin
Ali Hasan
Chief Medical & Healthcare Officer
Vitality
Bill Haynes
Head of Novo Nordisk Research Centre Oxford
Novo Nordisk
Brian Heaphy
SVP, Corporate Development
BMS
Christian Hein
VP Global Head of Digital Transformation & Innovation Execution
Novartis
Zach Henderson
Chief Commercial Officer
Glooko
Valerie Hepp
Digital and PHC Partnering Europe
Roche
Carl Hewett
Head of Medical Design Innovation
Sagentia Innovation
Andrew Hill
Product Innovation Lead
WTW
Berthold Hinzen
Head of BD&L Therapeutic Areas
Bayer
Regina Hodits
Managing Partner
Wellington Partners
Ben Hohn
Principal - BD, Pipeline and Launch Strategy & Emerging Pharma Lead
ZS Associates, Inc
Asaf Homossany
Senior Managing Director - EMEA
Nasdaq
Anne Horgan
Partner
Cambridge Innovation Capital
Baudouin Hue
Partner
Karista
Patrick Hughes
Director, Advisory Services EMEA
Nasdaq
Thomas Hummel
Digital Transformation Corporate Development
Fresenius Kabi
Wen Hwa Lee (He/him)
CEO and Chief Scientist
Action Against AMD
Sofia Ioannidou
Partner
Andera Partners
Catherine Isted
CFO
ReNeuron
Pierre-Louis Joffrin
CDO
Mogrify
Fredrik Johansson
CFO
Calliditas Therapeutics
Marc Julien
CEO
Diabeloop
Markus Kalousek
Global Head Search & Evaluation
Novartis
Tahera Kan
VP Transactions, Johnson & Johnson Innovation EMEA
Johnson & Johnson
Christoph Kausch
Managing Partner
MTIP
Oliver Keown
Managing Director
Intuitive Ventures
Maya Khurana
Health and Life Sciences Director
Oliver Wyman
Robert Kieval
EVP Strategic Partnerships
Veranex
Sven Kili
Chief Executive Officer
Antion Biosciences SA
Jan Kimpen
Chief Medical Officer
Philips
Linda Korthout
Director International Clinical Affairs
MCRA
Charity Kufaas
VP, Strategy & Business Development EMEA
Medtronic
Dima Kuzmin
Managing Director
4BIO Capital
Paul Landau
CEO
Careology
Werner Lanthaler
CEO
Evotec
Stephanie Léouzon
Partner
Torreya
Marta Helena Lesko
Head of BD Enabling Technologies
Merck KGaA
Sergio Levi
Vice President Strategic Alliances
Philips
Bruce Lichorowic
President & CEO
Galen Robotics
Angela Liedler
Managing Director
Precisis
Peter Llewellyn-Davies
CEO
invIOs
Rana Lonnen
Managing Director, dRx Capital
Novartis
Tim Luker
VP Venture Science, Corporate BD
Eli Lilly
Nanna Lüneborg
General Partner
Forbion
Franklin Maddux
Global CMO
Fresenius Medical Care
Priya Mande
Interim CEO
PsiOxus Therapeutics
Guy Martin
Deputy Editor
Pharma Letter
Anton Mat
Director of Business Development
ISA Pharmaceuticals
Giuseppe Mazza
CEO
Engitix Therapeutics
Jessica McCreadie
Principal
Octopus Ventures
Robbie McLaren
Partner
Latham & Watkins
Anita Meiklejohn
Principal
Fish & Richardson
Jason Mellad
CEO
Start Codon
Lisa Melton
Senior News Editor
Nature Biotechnology
John Milad
CEO
Quanta Dialysis Technologies
Tim Mitchell
VP Strategic Programs
NAMSA
Piers Morgan
CFO
Cellcentric
Tim Morris
COO/CFO
Humanigen
Parker Moss
Chief Commercial Officer
Genomics England
Rachel Moss
Partner
McKinsey
Jukka Muhonen
Director of Global Business Development and Alliance Management
Orion Corporation
Matthias Müllenbeck
Senior Vice President and Head of Global Business Development & Alliance Management
Merck KGaA
Arif Nathoo
CEO
Komodo Health
Michael Niddam
Co-Founder & Managing Director
Kamet Ventures
Laura Niklason
CEO
Humacyte
David Norton
Senior Lead Innovation Consultant
Royal Free London Foundation Trust
Caroline Noublanche
CEO
Apricity
Markus Ott
Head Global Market Access & Health Policy
Roche
Tej Panesar
Investment Director - Life Sciences
British Patient Capital
Francis Pang
VP Global Market Access
Orchard Therapeutics
Pierluigi Paracchi
CEO & Co-founder
Genenta Science
Sokratis Papafloratos
CEO
Numan
Nick Pattinson
Head of Product
Automata
Antoine Pau
Senior Partner
Truffle Capital
Morag Peberdy
Of Counsel
Covington & Burling
Elisa Petris
Partner
Syncona
Martin Pfister
Principal
HTGF
Jim Polson
Managing Director
FTI Consulting
Rebecca Pope (she/her)
UK Digital & Data Science Innovation Lead
Roche Products
Steven Powell
CEO
eTheRNA immunotherapies
Cody Powers
Principal
ZS Associates
Lord David Prior
Former Chair, NHS England;
Global Senior Advisor, Lazard; Chair, Cambridge Life Sciences Council
Tony Proctor
Partner
Potter Clarkson
Gil Rabbie
Digital Solutions & Capability Development Leader
Boston Scientific
Marc Ramis Castelltort
Venture Partner
Chasing Science
Nazar Rasul
VP Global Head of Digital
Fresenius Kabi
Tara Raveendran
Head of Healthcare & Life Sciences Research
Polar Capital
Bleddyn Rees
Chair, The Digital Health Society
Board Director, ECHAlliance
Stephen Reese
Partner
Clifford Chance
Brad Robling
VP, Lilly Ventures, Corporate BD
Eli Lilly
Chris Robson
CEO
Living With
Andrew Roddam
CEO
Our Future Health
Hanno Ronte
Partner
Monitor Deloitte
Kieran Rooney
VP, Strategic Alliances and Licensing
Amryt Pharma
Chris Rowe
Innovation Lead
Innovate UK
Laurie Rowe
Director & Founder
RED Medtech
Igor Rudychev
VP Enterprise Analytics
Horizon Therapeutics
Gunnar Sachs
Partner
Clifford Chance
Neil Sahota
United Nations Artificial Intelligence Advisor & Interim CEO
ACSILabs
Ed Saltzman
Head, Biotech Strategy
Lumanity
Antonio Sanchez-Cordero
WW VP Business Development & Strategy
Becton Dickinson
Arthur Sands
CEO
Nurix Inc.
Josep Sanfeliu
Managing Partner
Asabys
Diana Saraceni
Managing Partner
Panakès Partners
Fabian Scheugenpflug
Senior Ventures Associate
Startup Creasphere powered by Plug and Play
Isabella Schidrich
Senior Managing Director
Nasdaq
Susanne Schorsch
Vice President Business Development
Comphya
Eliane Schutte
Chief Executive Officer
Xeltis B.V.
Sara Secall
Partner
Inveready
Graziano Seghezzi
Managing Partner
Sofinnova
Nigel Sheail
Global Head of M&A and BD&L
Novartis
Tom Shepherd
CEO
Captor Therapeutics
João Siffert
CEO & President
Design Therapeutics
Tobias Silberzahn
Partner
McKinsey
Ari Silverman
Partner
Mavie Technologies
Stephanie Sirota
Partner and Chief Business Officer
RTW Investments
Ulrica Slåne Bjerke
CIO
Arctic Aurora LifeScience
Mark Slaughter
SVP Business Development
Sidekick Health
Rhoda Steel
Head of Community Impact
Johnson & Johnson UK
Anette Steenberg
CEO
Medicon Valley Alliance
Jérôme Stevens
General Manager & co-founder
Webhelp Medica
Johan Strömquist
CEO
NDA Group
Tina Tan
Executive Editor
FirstWord HealthTech
Susan Thomas
Clinical Director
Google Health UK
Nicki Thompson
CEO
Amphista Therapeutics
Steve Tolle
Partner
HLM Ventures
Gadi Toren
Investment Partner
Robert Bosch Venture Capital
Carina Tyrell
Chief of Staff & Investment Associate
Walden Catalyst Ventures
Andrew Udell
President, North America
Calliditas Therapeutics
Caoimhe Vallely-Gilroy
Head of Digital Health & Therapeutics
Healthcare Business of Merck KGaA
Josh Valman
CEO
RPD International
Valerie Vanhooren
CEO & Co-Founder
ONA Therapeutics
Erik van den Berg
CEO
AM Pharma
Sally van Kooten
VP Commercial Strategy
KalVista Pharmaceuticals
Edward van Wezel
Managing Partner
Biogeneration Ventures
Bonnie van Wilgenburg
Principal
Monograph Capital Partners
Wilfred Van Zuilen
President EMEA
Zimmer Biomet
Laurent Vandebrouck
CEO
Chronolife
Per Vegard Nerseth
CEO
CMR Surgical
Neil Ward
VP EMEA
Pacific Biosciences
Pnina Weitz
Global Head of Venture Capital Business Development & Relationship Management
Lonza
Ethan Wergelis-Isaacson
Digital Health Strategy
Otsuka
Jacob West
Director, Healthcare & Life Sciences
Microsoft
Nicklas Westerholm
CEO
Egetis Therapeutics
Anna Williamson
Senior Director, Business Development
Roche
Rupert Winckler
Head of EMEA BD
Olympus Corporation
Jonathan Wood
Regional Director
Abbott Vascular
Claire Woodthorpe
VP, Europe & COO
Lightpoint Medical
Donald Xu
Managing Director
Lynx Capital
Sarah Yusuf
Consultant Radiologists & Group Director
Sandwell and West Birmingham NHS Trust
Alexandra Zemp
Partner
McKinsey & Company
Eyal Zimlichman
Chief Innovation and Transformation Officer
Sheba Medical Centre
Klaas Zuideveld
CEO
Versameb
.jpeg)
.jpeg)
%2c%20UK%20Digital%20%26%20Data%20Science%20Innovation%20Lead%2c%20Roche.jpeg)
%20Peripheral%20Intervention%2c%20BD.jpeg)
